Monday, September 12, 2022

Cancer Screening

Cancer screening 

Liquid biopsy: non-invasive Circulating tumor DNA ctDNA, Circulating tumor cell CTC 

Evaluate Reports, Elizabeth Cairns, liquid biopsy, RNA, DNA, nuclear acid, nucleotides, protein 

Guardant Health Shield cancer screening Lunar-2 Eclipse trial 

Roche Foundation Health 

Grail Galleri multi-cancer early detection test $945 

Exact Sciences (Genomic Health) Cologuard $0 insurance-paid stool colon cancer screening test for average risk 45+, 10 DNA markers and blood hemoglobin 

Natera 
Freenome 
Invitae 
Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening 

Prenuvo whole-body MRI vs low dose CT scan, genetic 

No comments: